Anaphylaxis to additives in vaccines

被引:7
|
作者
Mahler, Vera [1 ]
Junker, Ann-Christine [1 ]
机构
[1] Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany
关键词
BOVINE SERUM-ALBUMIN; ALLERGIC REACTIONS; VACCINATION; IMMUNIZATION; GUIDELINES; ANTIBODIES; COMPLEMENT; DIPHTHERIA; CHILDREN; TETANUS;
D O I
10.1007/s40629-022-00215-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Anaphylaxis in connection with the administration of vaccines occurs only very rarely. Triggers of immunoglobulin IgE-mediated and non-IgE-mediated anaphylaxis—in addition to the active ingredient itself—may be excipients contained in the vaccine due to their special properties. Some of the excipients in medicinal products are the same compounds used as additives in food. Furthermore, residues from the manufacturing process (e.g., chicken egg white, casein, antibiotics, formaldehyde) or contaminants (e.g., from the primary packaging material) may be potential triggers of anaphylaxis in vaccines. This review article provides an overview of ingredients in vaccines that pose an allergenic risk potential. The components of COVID-19 vaccines approved and marketed in Germany are discussed with regard to their potential for triggering anaphylaxis and possible pathophysiological mechanisms involved. © 2022, The Author(s).
引用
收藏
页码:22 / 37
页数:16
相关论文
共 50 条
  • [31] IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines
    Yamaki, Kouya
    Nakashima, Takayuki
    Miyatake, Kenji
    Ishibashi, Yuki
    Ito, Ayaka
    Kuranishi, Ayu
    Taguchi, Akihito
    Morioka, Ayumi
    Yamamoto, Midori
    Yoshino, Shin
    IMMUNOLOGIC RESEARCH, 2014, 58 (01) : 106 - 117
  • [32] IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines
    Kouya Yamaki
    Takayuki Nakashima
    Kenji Miyatake
    Yuki Ishibashi
    Ayaka Ito
    Ayu Kuranishi
    Akihito Taguchi
    Ayumi Morioka
    Midori Yamamoto
    Shin Yoshino
    Immunologic Research, 2014, 58 : 106 - 117
  • [34] The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis
    Sobczak M.
    Pawliczak R.
    Clinical and Molecular Allergy, 20 (1)
  • [35] Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines
    Somiya, Masaharu
    Mine, Sohtaro
    Yasukawa, Kosuke
    Ikeda, Saki
    VACCINE, 2021, 39 (25) : 3313 - 3314
  • [36] Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program
    Toledo-Salinas, Carla
    Cecilia Scheffler-Mendoza, Selma
    Maria Castano-Jaramillo, Lina
    Antonio Ortega-Martell, Jose
    Estela Del Rio-Navarro, Blanca
    Maria Santibanez-Copado, Ana
    Luis Diaz-Ortega, Jose
    Baptista-Rosas, Raul
    Sanchez-Novoa, Paulina
    Garcia-Grimshaw, Miguel
    Ivan Valdes-Ferrer, Sergio
    Reyes-Teran, Gustavo
    Alejandro Mendoza-Hernandez, David
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (08) : 1593 - 1599
  • [37] Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines Not the usual suspects?
    de Chaisemartin, Luc
    Diep, Antoine
    Gonnin, Cecile
    Soria, Angele
    Barbaud, Annick
    Nicaise-Roland, Pascale
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (03) : 338 - 339
  • [38] Anaphylaxis and COVID-19 vaccines: Real-time interest using Google Trends
    Camacho, Bernardo
    Aguiar, Rita
    Tanno, Luciana Kase
    Ansotegui, Ignacio J.
    Morais-Almeida, Mario
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (08):
  • [39] Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines
    Sakaguchi, M
    Nakayama, T
    Inouye, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) : 1058 - 1061
  • [40] Anaphylaxis following H1N1 pandemic vaccines: Safety data in perspective
    Tavares, Fernanda
    Delaigle, Aurelie
    Slavin, Dorothy
    Bauchau, Vincent
    Fries, Louis
    Seifert, Harry
    VACCINE, 2011, 29 (37) : 6402 - 6407